# GCM Grosvenor Inc.: financial statements, quarterly

GCMG · Nasdaq · CIK 1819796 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gcmg.md) · [Financials](/companies/gcmg/financials.md) · [Filings](/companies/gcmg/filings.md) · [Insiders](/companies/gcmg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gcmg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [122](/filings/0001819796-24-000023.md) | [117 d](/filings/0001819796-26-000010.md) | [109](/filings/0001819796-25-000012.md) | [117](/filings/0001819796-25-000018.md) | [123](/filings/0001819796-25-000025.md) | [165 d](/filings/0001819796-26-000010.md) | [126](/filings/0001819796-26-000024.md) | [120](/filings/0001819796-26-000028.md) | [135](/filings/0001819796-25-000025.md) | [177 d](/filings/0001819796-26-000010.md) | [125](/filings/0001819796-26-000024.md) | [134](/filings/0001819796-26-000028.md) |
| Selling, general and administrative | $m | [21.4](/filings/0001819796-24-000023.md) | [24.9 d](/filings/0001819796-26-000010.md) | [25.2](/filings/0001819796-25-000012.md) | [28.2](/filings/0001819796-25-000018.md) | [24.6](/filings/0001819796-25-000025.md) | [26.3 d](/filings/0001819796-26-000010.md) | [28.3](/filings/0001819796-26-000024.md) | [25.5](/filings/0001819796-26-000028.md) | [24.7](/filings/0001819796-25-000025.md) | [26.3 d](/filings/0001819796-26-000010.md) | [28.9](/filings/0001819796-26-000024.md) | [27.7](/filings/0001819796-26-000028.md) |
| Operating income | $m | [23.9](/filings/0001819796-24-000023.md) | [13.1 d](/filings/0001819796-26-000010.md) | [(16.0)](/filings/0001819796-25-000012.md) | [20.8](/filings/0001819796-25-000018.md) | [25.0](/filings/0001819796-25-000025.md) | [43.6 d](/filings/0001819796-26-000010.md) | [15.3](/filings/0001819796-26-000024.md) | [19.2](/filings/0001819796-26-000028.md) | [44.2](/filings/0001819796-25-000025.md) | [54.7 d](/filings/0001819796-26-000010.md) | [20.5](/filings/0001819796-26-000024.md) | [35.5](/filings/0001819796-26-000028.md) |
| Interest expense | $m | [5.7](/filings/0001819796-23-000042.md) | [5.7 d](/filings/0001819796-24-000005.md) | [5.9](/filings/0001819796-24-000013.md) | not reported | [5.9](/filings/0001819796-25-000025.md) | [6.2 d](/filings/0001819796-26-000010.md) | not reported | not reported | [5.6](/filings/0001819796-25-000025.md) | [5.6 d](/filings/0001819796-26-000010.md) | not reported | not reported |
| Income tax | $m | [3.3](/filings/0001819796-24-000023.md) | [1.9 d](/filings/0001819796-26-000010.md) | [1.1](/filings/0001819796-25-000012.md) | [3.2](/filings/0001819796-25-000018.md) | [3.2](/filings/0001819796-25-000025.md) | [6.0 d](/filings/0001819796-26-000010.md) | [3.6](/filings/0001819796-26-000024.md) | [(0.2)](/filings/0001819796-26-000028.md) | [3.6](/filings/0001819796-25-000025.md) | [5.9 d](/filings/0001819796-26-000010.md) | [3.1](/filings/0001819796-26-000024.md) | [3.7](/filings/0001819796-26-000028.md) |
| Net income | $m | [5.9](/filings/0001819796-24-000023.md) | [3.3 d](/filings/0001819796-26-000010.md) | [2.1](/filings/0001819796-25-000012.md) | [4.8](/filings/0001819796-25-000018.md) | [4.2](/filings/0001819796-25-000025.md) | [7.6 d](/filings/0001819796-26-000010.md) | [0.5](/filings/0001819796-26-000024.md) | [15.4](/filings/0001819796-26-000028.md) | [10.5](/filings/0001819796-25-000025.md) | [19.0 d](/filings/0001819796-26-000010.md) | [5.5](/filings/0001819796-26-000024.md) | [9.6](/filings/0001819796-26-000028.md) |
| Diluted EPS | $ per share | [0.04](/filings/0001819796-24-000023.md) | not reported | [(0.13)](/filings/0001819796-25-000012.md) | [0.04](/filings/0001819796-25-000018.md) | [0.03](/filings/0001819796-25-000025.md) | not reported | [(0.02)](/filings/0001819796-26-000024.md) | [0.05](/filings/0001819796-26-000028.md) | [0.16](/filings/0001819796-25-000025.md) | not reported | [0.06](/filings/0001819796-26-000024.md) | [0.12](/filings/0001819796-26-000028.md) |
| Basic EPS | $ per share | [0.14](/filings/0001819796-24-000023.md) | not reported | [0.05](/filings/0001819796-25-000012.md) | [0.11](/filings/0001819796-25-000018.md) | [0.09](/filings/0001819796-25-000025.md) | not reported | [0.01](/filings/0001819796-26-000024.md) | [0.30](/filings/0001819796-26-000028.md) | [0.20](/filings/0001819796-25-000025.md) | not reported | [0.09](/filings/0001819796-26-000024.md) | [0.16](/filings/0001819796-26-000028.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [55.4](/filings/0001819796-23-000042.md) | [44.4](/filings/0001819796-25-000006.md) | [41.9](/filings/0001819796-24-000013.md) | [73.9](/filings/0001819796-24-000018.md) | [98.4](/filings/0001819796-24-000023.md) | [89.5](/filings/0001819796-26-000010.md) | [94.5](/filings/0001819796-25-000012.md) | [136](/filings/0001819796-25-000018.md) | [183](/filings/0001819796-25-000025.md) | [242](/filings/0001819796-26-000028.md) | [164](/filings/0001819796-26-000024.md) | [140](/filings/0001819796-26-000028.md) |
| Total assets | $m | [505](/filings/0001819796-23-000042.md) | [505](/filings/0001819796-25-000006.md) | [497](/filings/0001819796-24-000013.md) | [544](/filings/0001819796-24-000018.md) | [575](/filings/0001819796-24-000023.md) | [613](/filings/0001819796-26-000010.md) | [580](/filings/0001819796-25-000012.md) | [637](/filings/0001819796-25-000018.md) | [686](/filings/0001819796-25-000025.md) | [814](/filings/0001819796-26-000028.md) | [689](/filings/0001819796-26-000024.md) | [677](/filings/0001819796-26-000028.md) |
| Total liabilities | $m | [598](/filings/0001819796-23-000042.md) | [616](/filings/0001819796-25-000006.md) | [598](/filings/0001819796-24-000013.md) | [638](/filings/0001819796-24-000018.md) | [688](/filings/0001819796-24-000023.md) | [703](/filings/0001819796-26-000010.md) | [669](/filings/0001819796-25-000012.md) | [657](/filings/0001819796-25-000018.md) | [682](/filings/0001819796-25-000025.md) | [686](/filings/0001819796-26-000028.md) | [566](/filings/0001819796-26-000024.md) | [555](/filings/0001819796-26-000028.md) |
| Long-term debt | $m | [385](/filings/0001819796-23-000042.md) | [385](/filings/0001819796-25-000006.md) | [384](/filings/0001819796-24-000013.md) | [434](/filings/0001819796-24-000018.md) | [433](/filings/0001819796-24-000023.md) | [432](/filings/0001819796-26-000010.md) | [431](/filings/0001819796-25-000012.md) | [430](/filings/0001819796-25-000018.md) | [429](/filings/0001819796-25-000025.md) | [428](/filings/0001819796-26-000028.md) | [363](/filings/0001819796-26-000024.md) | [362](/filings/0001819796-26-000028.md) |
| Shareholders' equity | $m | [(24.7)](/filings/0001819796-23-000042.md) | [(27.6)](/filings/0001819796-25-000006.md) | [(26.4)](/filings/0001819796-24-000013.md) | [(28.5)](/filings/0001819796-24-000018.md) | [(31.9)](/filings/0001819796-24-000023.md) | [(27.6)](/filings/0001819796-26-000010.md) | [(28.3)](/filings/0001819796-25-000012.md) | [(12.3)](/filings/0001819796-25-000018.md) | [(7.4)](/filings/0001819796-25-000025.md) | [27.0](/filings/0001819796-26-000028.md) | [25.5](/filings/0001819796-26-000024.md) | [25.3](/filings/0001819796-26-000028.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [43.6 d](/filings/0001819796-24-000023.md) | [26.7 d](/filings/0001819796-26-000010.md) | [24.2](/filings/0001819796-25-000012.md) | [17.5 d](/filings/0001819796-25-000018.md) | [69.0 d](/filings/0001819796-25-000025.md) | [38.1 d](/filings/0001819796-26-000010.md) | [33.3](/filings/0001819796-26-000024.md) | [42.0 d](/filings/0001819796-26-000028.md) | [79.8 d](/filings/0001819796-25-000025.md) | [28.5 d](/filings/0001819796-26-000010.md) | [51.7](/filings/0001819796-26-000024.md) | [38.1 d](/filings/0001819796-26-000028.md) |
| Capital expenditure | $m | [0.5 d](/filings/0001819796-24-000023.md) | [2.4 d](/filings/0001819796-26-000010.md) | [4.2](/filings/0001819796-25-000012.md) | [4.7 d](/filings/0001819796-25-000018.md) | [6.7 d](/filings/0001819796-25-000025.md) | [1.1 d](/filings/0001819796-26-000010.md) | [1.2](/filings/0001819796-26-000024.md) | [1.2 d](/filings/0001819796-26-000028.md) | [1.5 d](/filings/0001819796-25-000025.md) | [4.6 d](/filings/0001819796-26-000010.md) | [3.8](/filings/0001819796-26-000024.md) | [1.9 d](/filings/0001819796-26-000028.md) |
| Share repurchases | $m | [0.0 d](/filings/0001819796-24-000023.md) | [0.0 d](/filings/0001819796-26-000010.md) | [0.0](/filings/0001819796-24-000013.md) | [0.0 d](/filings/0001819796-24-000018.md) | [0.0 d](/filings/0001819796-24-000023.md) | [0.0 d](/filings/0001819796-26-000010.md) | [0.0](/filings/0001819796-26-000024.md) | [0.0 d](/filings/0001819796-26-000028.md) | not reported | not reported | [17.5](/filings/0001819796-26-000024.md) | [2.2 d](/filings/0001819796-26-000028.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [188](/filings/0001819796-23-000042.md) | [187](/filings/0001819796-24-000013.md) | [188](/filings/0001819796-24-000018.md) | [188](/filings/0001819796-24-000023.md) | [188](/filings/0001819796-25-000012.md) | [190](/filings/0001819796-25-000018.md) | [191](/filings/0001819796-25-000025.md) | [190](/filings/0001819796-26-000024.md) | [196](/filings/0001819796-26-000028.md) | [197](/filings/0001819796-25-000025.md) | [205](/filings/0001819796-26-000024.md) | [204](/filings/0001819796-26-000028.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 42,259,797 at 2020-11-18, from the cover of the [10-Q filed 2020-11-20](/filings/0001213900-20-038575.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.